Westrock Coffee’s third-quarter results provide insight into how the company is navigating volatile commodity coffee prices, tariffs, and a major infrastructure transition. The quarter matters because it shows whether profitability can continue expanding even as reported sales decline due to pass-through effects. I’m watching closely to see if the Conway extract and ready-to-drink facility can turn its scale-up phase into lasting margin gains, and whether the firm can keep cutting leverage while producing cash. With revenue figures distorted by coffee prices and tariff refunds, attention has naturally shifted toward Adjusted EBITDA, cash flow, and balance-sheet strength.
For the third quarter ended September 30, 2026, Westrock Coffee reported net sales of $300.2 million, down 15.4% from $354.8 million in the prior-year period. Management pointed mainly to $26.1 million of tariff refunds expected to pass through to customers and the impact of lower average green coffee prices. Gross profit stayed essentially flat at $41.5 million, rising just 0.2%.
The company recorded a net loss of $10.0 million, narrower than the $19.1 million loss a year earlier. Consolidated Adjusted EBITDA reached $26.4 million, up 14.0% from $23.2 million and marking the sixth straight quarter of year-over-year growth in this measure.
By segment, Beverage Solutions posted net sales of $220.1 million (down 16.3%) and segment Adjusted EBITDA of $23.3 million (up 13.9%). Sustainable Sourcing & Traceability reported net sales of $80.1 million (down 12.8%) and segment Adjusted EBITDA of $3.2 million, compared with $5.8 million previously. Capital expenditures fell to $8.8 million from $18.1 million, highlighting lower capital needs as the Conway facility ramps up.
The company reaffirmed its 2026 Consolidated Adjusted EBITDA guidance of $90 million to $100 million and gave preliminary 2027 guidance of approximately $130 million.
Before the report, investors focused on whether Westrock Coffee could extend its streak of Adjusted EBITDA growth and show progress on cash flow and deleveraging. The results met those expectations with a narrower net loss, the 14% increase in Adjusted EBITDA, and a second consecutive quarter of positive free cash flow. The reaffirmed 2026 outlook plus the new preliminary 2027 target of roughly $130 million in Consolidated Adjusted EBITDA laid out a clear growth path. The company also completed an upsized $600 million refinancing in October 2026, pushing debt maturities to 2031 and improving near-term liquidity, which should help support confidence even with the headline revenue decline.
Looking ahead, the key question is whether Westrock Coffee can maintain its profitability momentum as the Conway facility continues to commercialize. Management has indicated that new customer programs should now contribute to EBITDA at higher incremental margins, which could drive further expansion if volumes grow as planned.
Cash flow and leverage stay important areas to watch. The company posted positive free cash flow for a second straight quarter and lowered its secured net leverage ratio to about 3.1 times at September 30, 2026, from 4.6 times a year earlier. Management has noted that leverage may rise temporarily in the fourth quarter and early next year due to annual incentive payouts and tariff refund pass-throughs, before the deleveraging trend resumes in the second quarter.
Commodity coffee prices and tariffs continue to add volatility to reported sales and working capital. Because much of the cost passes through to customers, investors should emphasize Adjusted EBITDA and free cash flow over raw revenue growth when assessing performance. The preliminary 2027 Adjusted EBITDA target of approximately $130 million offers a useful benchmark, though execution at Conway, customer volume commitments, and any shifts in industry demand will decide whether that path materializes.
I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. The tool helps filter based on technical patterns, fundamentals, and performance metrics, which can surface additional ideas worth reviewing alongside WEST.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where WEST declined for three days, in 228 of 294 cases, the price declined further within the following month. The odds of a continued downward trend are 78%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 63 cases where WEST's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 65%.
WEST broke above its upper Bollinger Band on October 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on WEST as a result. In 58 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
The Moving Average Convergence Divergence (MACD) for WEST just turned positive on October 15, 2026. Looking at past instances where WEST's MACD turned positive, the stock continued to rise in 28 of 47 cases over the following month. The odds of a continued upward trend are 60%.
WEST moved above its 50-day moving average on October 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for WEST crossed bullishly above the 50-day moving average on October 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +2.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where WEST advanced for three days, in 176 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Aroon Indicator entered an Uptrend today. In 109 of 150 cases where WEST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-32.373) is normal, around the industry mean (5.975). WEST has a moderately low P/E Ratio (-15.712) as compared to the industry average of (7.223). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (0.574) is also within normal values, averaging (5.003).
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. WEST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WEST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry FoodMajorDiversified